TGFB1, Human (Metelimumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-TGFB1, Human (Metelimumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityTGFB1, Human (Metelimumab biosimilar)
CloneMetelimumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG4 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsIF, IP, Neut, FuncS, ELISA, FCM, ICC
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human TGFB1 Recombinant Antibody. Metelimumab (CAT-192) is a human IgG4 monoclonal antibody that neutralizes TGF beta 1 which had been chosen for further development for the treatment of diffuse cutaneous systemic sclerosis, also known as scleroderma. It was dropped from further development in favour of fresolimumab, which was being developed by Genzyme as of 2006.
Immunogenn/a
Other NamesAnti-TGFB1 Recombinant Antibody, Research Grade Metelimumab, Anti-Human TGFB1 Recombinant Antibody, CAT-192, Antibody Drug Analogues, Monoclonal Antibody, YR1121, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 272780-74-2
Catalog #YR1121
Priceplease inquire
Order / More InfoTGFB1, Human (Metelimumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.